S1569 Impact of Delayed Diagnosis on Outcomes in Inflammatory Bowel Disease (IBD)

Introduction: Inflammatory Bowel Disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition of the gastrointestinal tract. Delayed diagnosis is hypothesized to influence disease outcomes adversely, yet its impact remains underexplored, particularly in Saudi Arabia. This study investigates the association between diagnostic delay and clinical outcomes in IBD patients. Methods: This cross-sectional study utilized data from a prospectively maintained IBD registry at King Faisal Specialist Hospital and Research Centre from September 2023 to September 2024. Inclusion criteria comprised patients aged ≥14 years with a confirmed diagnosis of IBD. Diagnostic delay, defined as the time from symptom onset to diagnosis, was categorized as <1 year, 1–2 years, and >2 years. Clinical outcomes included the need for intestinal surgery, >2 advanced therapies, and a composite outcome (surgery, advanced therapies, or disease progression). Associations were assessed using Chi-squared and Fisher’s exact tests. Results: The cohort included 412 patients (mean age at diagnosis: 24 years; 55% male; 68% CD, 32% UC). The average diagnostic delay was 1.48 years, with 26% experiencing delays >2 years. Patients with longer delays were more likely to have CD (P = 0.049), older age at diagnosis (P = 0.017), and stricturing disease phenotype in CD (P = 0.013). Delayed diagnosis (>2 years) was associated with a higher prevalence of intestinal surgery (32% vs 23%; P = 0.045) and borderline significance for the composite outcome (P = 0.062). No significant associations were found between delay and use of >2 advanced therapies. Conclusion: Diagnostic delay in IBD is prevalent and associated with worse outcomes, particularly in patients with CD. Efforts to minimize diagnostic delays may improve clinical outcomes and reduce the need for surgical interventions. Further research with larger cohorts and longitudinal follow-up is warranted to elucidate these associations.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001133736.47558.f2
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S1569 Impact of Delayed Diagnosis on Outcomes in Inflammatory Bowel Disease (IBD)

Sameer Desai, Wael Hussein Mahmoud, Mashary Attamimi, Abdulelah Almutairdi et al.
The American Journal of Gastroenterology
Inflammatory Bowel Disease
article

S1569 Impact of Delayed Diagnosis on Outcomes in Inflammatory Bowel Disease (IBD)

Sameer Desai, Wael Hussein Mahmoud, Mashary Attamimi, Abdulelah Almutairdi, Badr Al‐Bawardy, Lina Alyahya, Salman Almuammar
article en

Abstract

Introduction: Inflammatory Bowel Disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition of the gastrointestinal tract. Delayed diagnosis is hypothesized to influence disease outcomes adversely, yet its impact remains underexplored, particularly in Saudi Arabia. This study investigates the association between diagnostic delay and clinical outcomes in IBD patients. Methods: This cross-sectional study utilized data from a prospectively maintained IBD registry at King Faisal Specialist Hospital and Research Centre from September 2023 to September 2024. Inclusion criteria comprised patients aged ≥14 years with a confirmed diagnosis of IBD. Diagnostic delay, defined as the time from symptom onset to diagnosis, was categorized as <1 year, 1–2 years, and >2 years. Clinical outcomes included the need for intestinal surgery, >2 advanced therapies, and a composite outcome (surgery, advanced therapies, or disease progression). Associations were assessed using Chi-squared and Fisher’s exact tests. Results: The cohort included 412 patients (mean age at diagnosis: 24 years; 55% male; 68% CD, 32% UC). The average diagnostic delay was 1.48 years, with 26% experiencing delays >2 years. Patients with longer delays were more likely to have CD (P = 0.049), older age at diagnosis (P = 0.017), and stricturing disease phenotype in CD (P = 0.013). Delayed diagnosis (>2 years) was associated with a higher prevalence of intestinal surgery (32% vs 23%; P = 0.045) and borderline significance for the composite outcome (P = 0.062). No significant associations were found between delay and use of >2 advanced therapies. Conclusion: Diagnostic delay in IBD is prevalent and associated with worse outcomes, particularly in patients with CD. Efforts to minimize diagnostic delays may improve clinical outcomes and reduce the need for surgical interventions. Further research with larger cohorts and longitudinal follow-up is warranted to elucidate these associations.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 59%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.